Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT05726019

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05726019
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05726019. Randomized; single masking; primary purpose prevention. Start 2022-02-05 (actual); primary completion 2025-12-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
Acronym
COCAR
Condition
Acute Coronary Syndrome
Condition
Coronary Artery Bypass
Condition
Myocardial Reperfusion
Condition
Postpericardiotomy Syndrome
Condition
Postoperative Atrial Fibrilation
Condition
Perioperative Myocardial Infarction
Intervention (Drug)
Colchicine
Lead sponsor
University of Sao Paulo General Hospital (class: other)

Record details

Record id
cardio:ct-nct05726019
Content hash
2b2c9d084b0acb3c4ed1cebf1c461d9094fdad6f2662e131c3eeb6be56f33e1a